Limit each vial stopper to 15-20 total punctures maximum before rubber integrity degrades regardless of needle size
Potential Risks GLP-1 medications have shown promise in reducing the severity of OSA through weight loss and related physiological changes
Meanwhile, GLP-1s such as Ozempic (semaglutide) and Trulicity (dulaglutide) are very effective at managing post-meal blood sugars, have a low risk of hypoglycemia, and help with weight loss
Its easier to keep to a lower-calorie diet without always being hungry
* Correspondence: Ligang Zhou, [email protected] These authors have contributed equally to this work Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Ozempic was the first semaglutide drug, an GLP-1 (glucagon-like peptide 1) agonist and was approved to help improve blood sugar levels in patients with Type II diabetes in 2017
